Nanoviricides (NNVC) Total Non-Current Liabilities (2013 - 2019)

Nanoviricides has reported Total Non-Current Liabilities for 7 years, with the latest figure at $1.1 million in Q1 2019.

• Quarterly Total Non-Current Liabilities fell 52.68% year-over-year to $1.1 million in Q1 2019, while the trailing twelve-month figure through Mar 2019 was $1.1 million (down 52.68% YoY) and the FY2018 annual result came in at $866499.0, down 57.01% from the prior year.
• Total Non-Current Liabilities climbed to $1.1 million in Q1 2019 per NNVC's latest filing, from $866499.0 in the prior quarter.
• Over five years, Total Non-Current Liabilities peaked at $13.2 million in Q1 2015 and troughed at $866499.0 in Q2 2018.
• A 5-year average of $6.4 million and a median of $6.8 million in 2016 frame the typical range for Total Non-Current Liabilities.
• The sharpest annual moves came in 2015 and 2017: Total Non-Current Liabilities soared 43.0% in 2015, then tumbled 79.28% in 2017.
• Over 5 years, Total Non-Current Liabilities stood at $11.0 million in 2015, then slumped by 46.33% to $5.9 million in 2016, then surged by 32.29% to $7.8 million in 2017, then plunged by 88.9% to $866499.0 in 2018, then rose by 25.13% to $1.1 million in 2019.
• According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $1.1 million, $866499.0, and $2.3 million for Q1 2019, Q2 2018, and Q1 2018 respectively.